FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

24399811000001106: Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1741481000001119 Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1741491000001117 Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Is a Riociguat 2mg tablets 42 tablet true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has AMP Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has specific active ingredient Riociguat false Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Adempas 2mg tablets (Merck Sharp & Dohme (UK) Ltd) 42 tablet 2 x 21 tablets Has specific active ingredient Riociguat true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start